Atai Life Sciences Price to Free Cash Flow Ratio 2020-2025 | ATAI
Historical price to free cash flow ratio values for Atai Life Sciences (ATAI) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Atai Life Sciences Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2025-06-05 |
2.48 |
|
0.00 |
| 2025-03-31 |
1.36 |
$-0.48 |
0.00 |
| 2024-12-31 |
1.33 |
$-0.51 |
0.00 |
| 2024-09-30 |
1.16 |
$-0.54 |
0.00 |
| 2024-06-30 |
1.33 |
$-0.49 |
0.00 |
| 2024-03-31 |
1.97 |
$-0.54 |
0.00 |
| 2023-12-31 |
1.41 |
$-0.53 |
0.00 |
| 2023-09-30 |
1.29 |
$-0.55 |
0.00 |
| 2023-06-30 |
1.72 |
$-0.66 |
0.00 |
| 2023-03-31 |
1.81 |
$-0.66 |
0.00 |
| 2022-12-31 |
2.66 |
$-0.68 |
0.00 |
| 2022-09-30 |
3.31 |
$-0.65 |
0.00 |
| 2022-06-30 |
3.64 |
$-0.65 |
0.00 |
| 2022-03-31 |
5.09 |
$-0.62 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.495B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
